BIOMAT Database Logo BIOMAT Database Logo

Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. 1992

S Rong, and M Bodescot, and D Blair, and J Dunn, and T Nakamura, and K Mizuno, and M Park, and A Chan, and S Aaronson, and G F Vande Woude
ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Maryland 21702.

The met proto-oncogene is the tyrosine kinase growth factor receptor for hepatocyte growth factor/scatter factor (HGF/SF). It was previously shown that, like the oncogenic tpr-met, the mouse met proto-oncogene transforms NIH 3T3 cells. We have established NIH 3T3 cells stably expressing both human (Methu) and mouse (Metmu) met proto-oncogene products. The protein products are properly processed and appear on the cell surface. NIH 3T3 cells express endogenous mouse HGF/SF mRNA, suggesting an autocrine activation mechanism for transformation by Metmu. However, the tumor-forming activity of Methu in NIH 3T3 cells is very low compared with that of Metmu, but efficient tumorigenesis occurs when Methu and HGF/SFhu are coexpressed. These results are consistent with an autocrine transformation mechanism and suggest further that the endogenous murine factor inefficiently activates the tumorigenic potential of Methu. The tumorigenicity observed with reciprocal chimeric human and mouse receptors that exchange external ligand-binding domains supports this conclusion. We also show that HGF/SFhu expressed in NIH 3T3 cells produces tumors in nude mice.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090063 Proto-Oncogene Mas A protein that is encoded by the MAS1 gene. It is a receptor for ANGIOTENSIN 1-7 and acts as an antagonist of ANGIOTENSIN-2 TYPE 1 RECEPTOR. C-Mas Protein,II-Proto-Oncogene Proteins, Cellular,Mas Protein,Mas1 Protein,Proto-Oncogene Protein Mas,Proto-Oncogene Proteins C-Mas-1,C Mas Protein,C-Mas-1, Proto-Oncogene Proteins,Cellular II-Proto-Oncogene Proteins,II Proto Oncogene Proteins, Cellular,Mas, Proto-Oncogene,Protein Mas, Proto-Oncogene,Protein, C-Mas,Protein, Mas,Protein, Mas1,Proteins, Cellular II-Proto-Oncogene,Proto Oncogene Mas,Proto Oncogene Proteins C Mas 1

Related Publications

S Rong, and M Bodescot, and D Blair, and J Dunn, and T Nakamura, and K Mizuno, and M Park, and A Chan, and S Aaronson, and G F Vande Woude
Autocrine mechanism for met proto-oncogene tumorigenicity.
January 1994, Cold Spring Harbor symposia on quantitative biology,
S Rong, and M Bodescot, and D Blair, and J Dunn, and T Nakamura, and K Mizuno, and M Park, and A Chan, and S Aaronson, and G F Vande Woude
Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product.
December 1993, Biochimica et biophysica acta,
S Rong, and M Bodescot, and D Blair, and J Dunn, and T Nakamura, and K Mizuno, and M Park, and A Chan, and S Aaronson, and G F Vande Woude
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.
February 1991, Science (New York, N.Y.),
S Rong, and M Bodescot, and D Blair, and J Dunn, and T Nakamura, and K Mizuno, and M Park, and A Chan, and S Aaronson, and G F Vande Woude
Coexpression of hepatocyte growth factor and c-Met proto-oncogene product in synovial sarcoma.
October 1998, Pathology international,
S Rong, and M Bodescot, and D Blair, and J Dunn, and T Nakamura, and K Mizuno, and M Park, and A Chan, and S Aaronson, and G F Vande Woude
Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer.
November 1994, Cancer research,
S Rong, and M Bodescot, and D Blair, and J Dunn, and T Nakamura, and K Mizuno, and M Park, and A Chan, and S Aaronson, and G F Vande Woude
Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
April 1997, Hepatology (Baltimore, Md.),
S Rong, and M Bodescot, and D Blair, and J Dunn, and T Nakamura, and K Mizuno, and M Park, and A Chan, and S Aaronson, and G F Vande Woude
Structural and functional characterization of the mouse c-met proto-oncogene (hepatocyte growth factor receptor) promoter.
February 1998, Biochimica et biophysica acta,
S Rong, and M Bodescot, and D Blair, and J Dunn, and T Nakamura, and K Mizuno, and M Park, and A Chan, and S Aaronson, and G F Vande Woude
Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma.
March 1997, Hepatology (Baltimore, Md.),
S Rong, and M Bodescot, and D Blair, and J Dunn, and T Nakamura, and K Mizuno, and M Park, and A Chan, and S Aaronson, and G F Vande Woude
Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease.
February 2001, Blood,
S Rong, and M Bodescot, and D Blair, and J Dunn, and T Nakamura, and K Mizuno, and M Park, and A Chan, and S Aaronson, and G F Vande Woude
Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET proto-oncogene.
July 1994, Cellular and molecular biology (Noisy-le-Grand, France),
Copied contents to your clipboard!